HOME > Business Wire > Article
SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to Accelerate Global Expansion
IRVINE, Calif.--( BUSINESS WIRE )-- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that Dr. Ewen Chee, founder of Singapore’s leading aesthetic medical company Aesthetic Healthcare Holdings (“AHH”), has been appointed President of AHH and Lead Doctor for Asia Strategy at SBC Medical Group. In this role, Dr. Chee will support physician recruitment and training across the Asia-Pacific region, contributing to SBC’s global strategy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250825055997/en/

SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to Accelerate Global Expansion
Singapore is internationally recognized as a trusted destination for aesthetic medicine, supported by its robust medical infrastructure and stringent regulatory environment. Leveraging its geographic advantages, the country attracts patients from neighboring Indonesia, Malaysia, Thailand, and Vietnam, and has developed into a center of medical tourism, establishing itself as the “Aesthetic Medicine Hub of Asia.”
In this environment, Dr. Chee has accumulated more than 20 years of clinical experience and is regarded as a pioneer of aesthetic medicine in Singapore. In 1999, he founded The Chelsea Clinic, among the first to introduce IPL treatments domestically. He has served as an international trainer in various types of fillers, lasers, botulinum toxin, and thread lifts. In addition, he acted as Co-Chair of the Asia-Pacific Thread Lift Meeting (APEM), earning broad international recognition through education and speaking activities. Dr. Chee is also a certified physician of the American Academy of Aesthetic Medicine (AAAM), with his expertise presented at numerous international congresses and workshops.
Looking ahead, SBC will leverage Dr. Chee’s expertise and AHH’s brand portfolio to establish a scalable platform for physician recruitment and training across Asia-Pacific. Anchored by its group purpose, “Contributing to the happiness of people worldwide through medical innovation,” the Group is building a foundation for sustainable growth and expanding its leadership position in the global aesthetic medicine industry.
About Aesthetic Healthcare Holdings Pte. Ltd.
AHH is based in Singapore and operates aesthetic medical clinics, family clinics, and quick facial aesthetics outlets. The founder, Dr. Ewen Chee, is known as one of the pioneers in the field of aesthetic medicine in Singapore and is a co-chair of the first Asia Pacific Thread Lift Conference (APEM) and a board-certified physician by the American Academy of Aesthetic Medicine. He is a frequent speaker at international conferences and workshops, and his expertise and knowledge have been featured in numerous scientific publications.
AHH Major brands and number of clinics:
- The Chelsea Clinics (2 locations) https://chelseaclinic.com.sg/
- Gangnam Laser Clinic (1 location) https://www.gangnamlaser.com/
- SkinGo! (16 locations) https://skingo.sg/
- Family clinics (2 locations)
About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensing of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.
For more information, visit https://sbc-holdings.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250825055997/en/
Contacts
SBC Medical Group Holdings Incorporated (Asia)
Hikaru Fukui / Head of Investor Relations E-mail:
ir@sbc-holdings.com
Akiko Wakiyama / Head of Public Relations E-mail:
pr@sbc.or.jp
ICR LLC (In the US)
Bill Zima / Managing Partner Email:
bill.zima@icrinc.com
Source: SBC Medical Group Holdings Incorporated
Business Wire
-
08/27 13:00 2025 Drone Soccer World Cup to Be Held in Jeonju, the City of Drone So...
-
08/27 12:15 Sompo to Acquire Aspen for $3.5 Billion
-
08/27 12:00 Renesas Introduces Ultra-Low-Power RL78/L23 MCUs for Next-Generation S...
-
08/27 02:00 FPT and Smart Holdings Launch Joint Venture to Support Digital Transfo...
-
08/27 01:00 EdgeConneX Establishes 350MW Data Center Platform in Japan's Powerhous...
-
08/27 00:22 Telexistence, Launching a Robotic Motion Dataset Generation Service in...
-
08/26 14:00 Rigaku Launches Sales of the XHEMIS TX-3000, a TXRF Analytical System ...
-
08/26 13:00 Sample Data Available for JPXI Customized Data on Director and Auditor...
-
08/26 12:30 Asahi Kasei to Double Production Capacity for PIMEL™ Photosensitive ...
-
08/26 04:00 Toyoda Gosei Develops “METEOCOAT” Painting Technology That Gives O...
-
08/26 03:00 Mitsubishi Electric’s DX Innovation Center Achieves ISO 9001 Certifi...
-
08/25 13:00 Capcom’s Resident Evil Requiem Wins Most Honors with Four Awards at ...
-
08/25 12:00 iECURE to Present Initial OTC-HOPE Clinical Trial Data of ECUR-506 in ...
-
08/25 09:56 Otsuka Medical Devices Receives Manufacturing and Marketing Approval f...
-
08/25 07:00 SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to...
-
08/25 06:10 Kao Opens New Tertiary Amine Production Plant in U.S. to Meet Global G...
-
08/25 03:00 Mitsubishi Electric Signs Collaboration Agreement with ITRI and TTL Jh...
-
08/21 14:00 SkyDrive and Whitesky Forge Strategic Alliance to Launch eVTOL Operati...
-
08/21 12:00 New Renesas Ultra-Low Power MCU with Advanced Security and Targeted Pe...
-
08/21 08:30 L&T Technology Services Launches PLxAI, Proprietary GenAI Framewor...
-
08/21 03:00 Mitsubishi Electric Selected as Representative Organization for JAXA...
-
08/21 02:00 Toshiba Releases Automotive Photorelay in a Small Package that Achieve...
-
08/21 01:01 NIPPON KINZOKU: New Launch of “STA Finish” Stainless Steel for Hig...
-
08/20 13:30 Nanoco Reorganizes R&D and Invests in New Technology Resources for...
-
08/20 13:30 Helm.ai and Honda Motor Co. Agree to Multi-Year ADAS Joint Development...
-
08/20 12:00 New Renesas USB-C Power Solution with Innovative Three-Level Topology ...
-
08/20 11:57 ClearStrand-ASD, First-of-Its-Kind Autism Screening Tool, Now Availabl...
-
08/20 05:30 ‘Beyond Discrete – Sensing the Future’ Murata showcases Next-Gen...
-
08/20 04:58 Kioxia Achieves Successful Prototyping of 5TB Large-Capacity and 64GB/...
-
08/19 13:00 Nikkiso Selected to Provide Regasification Systems and Engineering Ser...